The results showed that expression of SLC39A1 was correlated with OS in male patients (P = 0.003) and patients with young age (≤60) (P = 0.013), poorly differentiated tumor (P = 0.007) and clinical stage 1 (P = 0.012) (Figure 4(a)). The gene discussed is SLC39A1; the disease is neoplasm.